| Alema Harrington, | |
|
9160 S 300 W Ste 13, Sandy, UT 84070-2656 | |
| (801) 808-2994 | |
| Not Available |
| Full Name | Alema Harrington |
|---|---|
| Gender | Male |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 9160 S 300 W Ste 13, Sandy, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154834398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 9102940-6006 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alema Harrington, 9160 S 300 W Ste 13, Sandy, UT 84070-2656 Ph: () - | Alema Harrington, 9160 S 300 W Ste 13, Sandy, UT 84070-2656 Ph: (801) 808-2994 |
News Archive
Linagliptin phase III data were presented for the first time this week at the 70th Scientific Sessions of the American Diabetes Association (ADA), showing that this investigational compound, a dipeptidyl peptidase (DPP)-4 inhibitor, achieved significant, sustained and clinically meaningful reductions in blood glucose as measured by haemoglobin A1c (HbA1c), fasting plasma glucose (FPG), and postprandial glucose (PPG) concentrations.(1-6) Linagliptin is being investigated by Boehringer Ingelheim as a once-daily oral treatment in type 2 diabetes.
Improving emotional well-being and preventing depression in young people between 16 and 22 years old is the main objective of MyMoodCoach, an app developed by a European research team, in which the Psychology and Technology Laboratory (LabPsiTec) of the Universitat Jaume I of Castellón participated.
Synta Pharmaceuticals Corp. announced that results of a Phase 1 study of ganetespib in combination with docetaxel in solid tumors were presented at the Annual Meeting of the European Society of Medical Oncology in Stockholm, Sweden.
A comparison study of nearly 1,900 patients published in Perfusion, a peer-reviewed academic journal, questions the long-standing practice of basing blood transfusion decisions on a single low hematocrit measurement result. In the study, titled Is it the Patient or the Physician who Cannot Tolerate Anemia?, researchers showed that a single measure of hematocrit is not a reliable indicator of transfusion need and that lower-than-normal hemoglobin levels have no adverse impact on patients.
Researchers from the University of Granada have developed a new, simple and non invasive method which allows to determine whether a child aged 2-4 suffers from celiac disease or not without the necessity of a blood extraction.
› Verified 7 days ago
Jacqueline Hyde, Counselor Medicare: Not Enrolled in Medicare Practice Location: 10151 Majestic Canyon Rd, Sandy, UT 84092 Phone: 801-809-5050 | |
Jason Vaughn Shoemaker, PHD Counselor Medicare: Not Enrolled in Medicare Practice Location: 9045 S 1300 E, Sandy, UT 84094 Phone: 801-666-6834 | |
Mrs. Sandra Lee Chew, MS, CMHC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1270 E 8600 S Ste 3, Sandy, UT 84094 Phone: 801-676-9160 Fax: 801-606-2766 | |
David S Bridgeman, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 781 E Autumn Field Dr, Sandy, UT 84094 Phone: 801-633-3928 | |
Mrs. Bonita Gray Kolb, L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 8160 Highland Dr, Building A, Sandy, UT 84093 Phone: 801-831-4339 | |
Stephen Beyers, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 9192 S 300 W, #19, Sandy, UT 84070 Phone: 801-554-3191 Fax: 801-523-9239 | |
Wendy Meyer, CMHC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 9361 S 300 E, Sandy, UT 84070 Phone: 801-826-5000 |